Molecules (Feb 2014)

Synthetic Fosmidomycin Analogues with Altered Chelating Moieties Do Not Inhibit 1-Deoxy-D-xylulose 5-phosphate Reductoisomerase or Plasmodium falciparum Growth In Vitro

  • René Chofor,
  • Martijn D.P. Risseeuw,
  • Jenny Pouyez,
  • Chinchu Johny,
  • Johan Wouters,
  • Cynthia S. Dowd,
  • Robin D. Couch,
  • Serge Van Calenbergh

DOI
https://doi.org/10.3390/molecules19022571
Journal volume & issue
Vol. 19, no. 2
pp. 2571 – 2587

Abstract

Read online

Fourteen new fosmidomycin analogues with altered metal chelating groups were prepared and evaluated for inhibition of E. coli Dxr, M. tuberculosis Dxr and the growth of P. falciparum K1 in human erythrocytes. None of the synthesized compounds showed activity against either enzyme or the Plasmodia. This study further underlines the importance of the hydroxamate functionality and illustrates that identifying effective alternative bidentate ligands for this target enzyme is challenging.

Keywords